Naturally arising HIV-1 Nef variants conferring escape from cytotoxic T lymphocytes influence viral entry co-receptor expression and susceptibility to superinfection

Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):422-7. doi: 10.1016/j.bbrc.2010.11.047. Epub 2010 Nov 17.

Abstract

HIV-1 Nef is a key factor for pathogenesis and is known to down-regulate functionally important molecules, including viral entry co-receptor CCR5 and CXCR4, from the surface of HIV-infected cells. Some of these Nef activities are mediated by the well-conserved proline-rich region of Nef, and this region is highly targeted by cytotoxic T lymphocytes (CTLs). In the present study, we asked whether Nef variants selected under CTL-mediated selective pressure in vivo may constrain these important Nef activities. The analysis of autologous nef sequences isolated from a cohort of total 235 subjects in Japan revealed that the subjects showing amino acid variations, such as Arg75Thr and Tyr85Phe, located within the proline-rich region were significantly over-represented by those having HLA-B*3501. CTL assays corroborated that these mutations conferred escape from HLA-B(∗)3501-restricted CTLs. The Arg75Thr variant Nef selectively impaired CCR5, but not CXCR4, down-regulation activity from the cell surface; whereas the Tyr85Phe variant Nef affected neither CCR5 nor CXCR4 down-regulation activity. Moreover, the cells expressing the Arg75Thr variant Nef significantly impaired protection from superinfection by CCR5-tropic, but not CXCR4-tropic, viruses. These results highlighted the importance of certain Nef-specific CTLs in modulation of viral co-receptor down-regulation activity and protection from HIV-1 superinfection, providing us with additional insight into vaccine design.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / immunology
  • Amino Acid Substitution
  • DNA Mutational Analysis
  • Down-Regulation
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • HLA-B Antigens / immunology
  • HLA-B35 Antigen
  • Humans
  • Mutation
  • Receptors, CCR5 / immunology
  • Receptors, CXCR4 / immunology
  • Superinfection / immunology*
  • Superinfection / virology
  • T-Lymphocytes, Cytotoxic / immunology*
  • T-Lymphocytes, Cytotoxic / virology
  • Virus Internalization*
  • nef Gene Products, Human Immunodeficiency Virus / genetics
  • nef Gene Products, Human Immunodeficiency Virus / immunology*

Substances

  • AIDS Vaccines
  • CXCR4 protein, human
  • HLA-B Antigens
  • HLA-B*35:01 antigen
  • HLA-B35 Antigen
  • Receptors, CCR5
  • Receptors, CXCR4
  • nef Gene Products, Human Immunodeficiency Virus